<!DOCTYPE html>
<html lang="en">
 <head>
  <meta charset="utf-8"/>
  <meta content="origin" name="referrer"/>
  <meta content="/images/branding/googleg/1x/googleg_standard_color_128dp.png" itemprop="image"/>
  <title>
   Is Focal, Inc. a subsidiary that operates independently or under Genzyme's control? - Google Search
  </title>
  <style>
   a{color:#1a0dab;text-decoration:none;-webkit-tap-highlight-color:rgba(0,0,0,.10)}a:visited{color:#4b11a8}a:hover{text-decoration:underline}img{border:0}html{font-family:arial,sans-serif;font-size:14px;line-height:20px;-webkit-text-size-adjust:100%;color:#3c4043;word-wrap:break-word;background-color:#fff}.bz1lBb{background-color:#fff;height:93px;}.KP7LCb{background-color:#fff;padding-left:4px}.BsXmcf{position:absolute;height:1px;left:0;right:0;background-color:#dadce0}.cOl4Id{background-color:#fff}.bRsWnc{overflow:hidden}.N6RWV{height:51px}.Uv67qb{font-size:14px;line-height:20px;font-weight:bold;display:flex}.Uv67qb a,.Uv67qb span{color:#5e5e5e;height:20px;margin:4px 12px 1px;display:block;flex:none;text-align:center;}.OXXup{border-bottom:2px solid #1f1f1f}.Uv67qb .OXXup{font-weight:bold;color:#1f1f1f}a.eZt8xd:visited{color:#5e5e5e}.FElbsf{border-left:1px solid #dadce0}header article{overflow:visible}.Pg70bf{height:39px;display:-webkit-box;display:flex;display:flex;width:100%}.H0PQec{position:relative;flex:1}.Pg70bf{height:26px}.hlm7Y{height:46px;margin-top:26px;border-radius:25px;width:auto;background:#fff;box-shadow:0px 2px 6px rgba(60,64,67,0.16)}.sbc{display:flex}.Pg70bf input{}.x{width:26px;color:#70757a;line-height:40px;margin-top:3px;font:27px/38px arial, sans-serif}#qdClwb{flex:0 0 auto;padding:0;height:33px;margin-top:5px;border-top-right-radius:25px;border-bottom-right-radius:25px;width:48px;background:#fff;border:0;border-left:1px solid #dadce0;background-image:url('data:image/svg+xml,\00003csvg height="37px" width="37px" xmlns="http://www.w3.org/2000/svg">\00003cg fill="none" stroke="%234285F4">\00003cellipse cx="16.5" cy="16" rx="5.4" ry="5.4" stroke-width="2px">\00003c/ellipse>\00003cpath d="M22 21.3l4.3 4.3" stroke-linecap="round" stroke-width="2px">\00003c/path>\00003c/g>\00003c/svg>');}.sc{font-size:16px;position:absolute;top:48px;left:0;right:0;box-shadow:0 2px 5px rgba(0,0,0,.2);z-index:2;background-color:#fff}.sc>div{padding:10px 20px}.scs{background-color:#fafafa;}.noHIxc{display:block;font-size:16px;padding:0 0 0 8px;flex:1;height:35px;outline:none;border:none;width:100%;-webkit-tap-highlight-color:rgba(0,0,0,0);overflow:hidden;padding:4px 0 0 20px}.sbc input[type=text]{background:none}html{background-color:#fff;}body{padding:0;}body{margin:0 auto 0 156px;max-width:652px;min-width:652px;padding:0 8px}.cOl4Id{text-align:center;padding:32px 28px 0 24px;position:absolute;left:0;top:0}footer{text-align:center;margin-top:18px}footer a,footer a:visited,.smiUbb{color:#70757a}.xeDNfc{margin:0 13px;display:inline-block}#EOlPnc{margin-top:36px}#EOlPnc>div{margin:20px}.Srfpq{color:#70757a}
  </style>
 </head>
 <body jsmodel="hspDDf ">
  <header id="hdr">
   <div class="cOl4Id">
    <a href="/?sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QOwgC">
     <svg aria-label="Google" fill="none" height="36" stroke="#4285f4" stroke-width="18" viewbox="0 0 520 174" width="92">
      <path d="M69 70.4l61 0m-9 3.5a56 57 0 1 1-17-47" stroke-width="19px">
      </path>
      <ellipse cx="179" cy="90" rx="33" ry="34" stroke="#ea4335">
      </ellipse>
      <ellipse cx="270" cy="90" rx="33" ry="34" stroke="#fbbc04">
      </ellipse>
      <ellipse cx="358" cy="90" rx="32" ry="34" stroke-width="17px">
      </ellipse>
      <path d="M391 49l0 73l-2 0a 22 22-30 0 1-59 24">
      </path>
      <path d="M423 5l0 130" style="stroke:#34a853">
      </path>
      <path d="M509 110a32 35-3 1 1 3-29M517 76l-63 24" stroke="#ea4335" stroke-width="16px">
      </path>
     </svg>
    </a>
   </div>
   <div class="bz1lBb">
    <form class="Pg70bf hlm7Y" id="sf">
     <input name="num" type="hidden" value="100"/>
     <input name="lr" type="hidden" value="lang_en"/>
     <input name="sca_esv" type="hidden" value="838ca97d1d112653"/>
     <input name="sca_upv" type="hidden" value="1"/>
     <input name="hl" type="hidden" value="en"/>
     <input name="gbv" type="hidden" value="1"/>
     <input name="gl" type="hidden" value="us"/>
     <input name="tbs" type="hidden" value="lr:lang_1en"/>
     <div class="H0PQec">
      <div class="sbc esbc">
       <input autocapitalize="none" autocomplete="off" class="noHIxc" name="q" spellcheck="false" type="text" value="Is Focal, Inc. a subsidiary that operates independently or under Genzyme's control?"/>
       <input name="oq" type="hidden"/>
       <input name="aqs" type="hidden"/>
       <div class="sc">
       </div>
      </div>
     </div>
     <button id="qdClwb" type="submit">
     </button>
    </form>
   </div>
  </header>
  <div id="main">
   <div>
    <div class="KP7LCb">
     <div class="bRsWnc">
      <div class="N6RWV">
       <div class="Pg70bf Uv67qb">
        <span class="OXXup">
         All
        </span>
        <a class="eZt8xd" href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=bks&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q_AUIBigB">
         Books
        </a>
        <a class="eZt8xd" href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=isch&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q_AUIBygC">
         Images
        </a>
        <a class="eZt8xd" href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=nws&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q_AUICCgD">
         News
        </a>
        <a href="/url?q=https://maps.google.com/maps%3Fhl%3Den%26q%3DIs%2BFocal,%2BInc.%2Ba%2Bsubsidiary%2Bthat%2Boperates%2Bindependently%2Bor%2Bunder%2BGenzyme%2527s%2Bcontrol%253F%26iflsig%3DAL9hbdgAAAAAZpa0fzCUda8Isoo66B6MXiluKkZXzuXc%26gbv%3D1%26lr%3Dlang_en%26gl%3Dus%26num%3D100%26um%3D1%26ie%3DUTF-8%26ved%3D1t:200713%26ictx%3D111&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QiaAMCAkoBA&amp;usg=AOvVaw0lukTqnktDGcIvkl5dhFRb">
         Maps
        </a>
        <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=vid&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q_AUICigF">
         Videos
        </a>
        <a href="/url?q=/search%3Fq%3DIs%2BFocal,%2BInc.%2Ba%2Bsubsidiary%2Bthat%2Boperates%2Bindependently%2Bor%2Bunder%2BGenzyme%2527s%2Bcontrol%253F%26num%3D100%26lr%3Dlang_en%26sca_esv%3D838ca97d1d112653%26sca_upv%3D1%26hl%3Den%26gbv%3D1%26gl%3Dus%26tbs%3Dlr:lang_1en%26tbm%3Dshop%26source%3Dlnms%26ved%3D1t:200713%26ictx%3D111&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QiaAMCAsoBg&amp;usg=AOvVaw2BFBV2HCwqB5pIghiAVTCA">
         Shopping
        </a>
        <div class="FElbsf">
         <a href="/advanced_search" id="st-toggle" role="button" style="white-space:nowrap">
          Search tools
         </a>
        </div>
       </div>
      </div>
     </div>
    </div>
    <div class="Pg70bf wEsjbd Gx5Zad xpd EtOod pkphOe" id="st-card">
     <style>
      .wEsjbd{height:44px;white-space:nowrap}.coPU8c{height:60px;-webkit-overflow-scrolling:touch;overflow-x:auto;overflow-y:hidden}.Xj2aue{height:44px;overflow:hidden}.RnNGze{margin:11px 16px}.wEsjbd div,.wEsjbd a,.wEsjbd li{outline-width:0;outline:none}
     </style>
     <div class="Xj2aue">
      <div class="coPU8c">
       <div class="RnNGze">
        <style>
         .PA9J5{display:inline-block}.RXaOfd,.tbcPJb{display:inline-block;height:22px;position:relative;padding-top:0;padding-bottom:0;padding-right:16px;padding-left:0;line-height:22px;cursor:pointer;text-transform:uppercase;font-size:12px;color:#70757a}.sa1toc{background:#fff;display:none;position:absolute;border:1px solid #dadce0;box-shadow:0 2px 4px rgba(0,0,0,.3);margin:0;white-space:nowrap;z-index:103;line-height:17px;padding-top:5px;padding-bottom:5px;padding-left:0}.PA9J5:hover .sa1toc{display:block}.mGSy8d a:active,.RXaOfd:active{color:#4285f4}
        </style>
        <div class="PA9J5">
         <div class="RXaOfd vQYuGf" role="button" tabindex="0">
          <style>
           .TWMOUc{display:inline-block;padding-right:14px;white-space:nowrap}.vQYuGf{font-weight:bold}.OmTIzf{border-color:#909090 transparent;border-style:solid;border-width:4px 4px 0 4px;width:0;height:0;margin-left:-10px;top:50%;margin-top:-2px;position:absolute}.RXaOfd:active .OmTIzf{border-color:#4285f4 transparent}
          </style>
          <div class="TWMOUc">
           Search English pages
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <style>
           .ozatM{font-size:12px;text-transform:uppercase}.ozatM .yNFsl,.ozatM li{list-style-type:none;list-style-position:outside;list-style-image:none}.yNFsl.SkUj4c,.yNFsl a{color:#70757a;text-decoration:none;padding:6px 44px 6px 14px;line-height:17px;display:block}.SkUj4c{background-image:url(//ssl.gstatic.com/ui/v1/menu/checkmark2.png);background-position:right center;background-repeat:no-repeat}.SkUj4c:active{background-color:#f8f9fa}
          </style>
          <li class="yNFsl">
           <style>
            .tbcPJb a{color:#70757a;text-decoration:none}
           </style>
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbas=0&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QpwUIDA">
            Any language
           </a>
          </li>
          <li class="yNFsl SkUj4c">
           Search English pages
          </li>
         </ul>
        </div>
        <div class="PA9J5">
         <div class="RXaOfd" role="button" tabindex="0">
          <div class="TWMOUc">
           Any time
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <li class="yNFsl SkUj4c">
           Any time
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:h&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QpwUIDw">
            Past hour
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:d&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QpwUIEA">
            Past 24 hours
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:w&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QpwUIEQ">
            Past week
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:m&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QpwUIEg">
            Past month
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:y&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QpwUIEw">
            Past year
           </a>
          </li>
         </ul>
        </div>
        <div class="PA9J5">
         <div class="RXaOfd" role="button" tabindex="0">
          <div class="TWMOUc">
           All results
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <li class="yNFsl SkUj4c">
           All results
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=li:1&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QpwUIFQ">
            Verbatim
           </a>
          </li>
         </ul>
        </div>
        <div class="tbcPJb" role="button" tabindex="0">
         <a href="https://www.google.com/search?hl=en&amp;source=hp&amp;q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;btnG=Google+Search&amp;iflsig=AL9hbdgAAAAAZpa0fzCUda8Isoo66B6MXiluKkZXzuXc&amp;gbv=1&amp;gl=us&amp;num=100">
          Clear
         </a>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div class="BsXmcf">
   </div>
   <style>
    .Gx5Zad{margin-bottom:30px;margin:0px 0px 8px;}.pkphOe{font-size:14px;line-height:22px;}.EtOod>*:first-child{border-top-left-radius:8px;border-top-right-radius:8px}.EtOod>*:last-child{border-bottom-left-radius:8px;border-bottom-right-radius:8px}.EtOod.avPKgf>*:last-child{border-bottom-left-radius:4px}.EtOod>.qxDOhb>*:first-child{border-top-left-radius:8px;border-top-right-radius:8px}.EtOod>.qxDOhb>*:last-child{border-bottom-left-radius:8px;border-bottom-right-radius:8px}.fP1Qef{background:transparent !important;box-shadow:none !important;border:none !important}.rl7ilb{display:block;clear:both}.egMi0{margin-bottom:-23px}.kCrYT{padding:16px 14px 12px}a.fdYsqf{color:#4b11a8}.sCuL3{position:absolute;width:100%;top:0;left:0;padding-top:1px;margin-bottom:-1px}.j039Wc{padding-top:28px;margin-bottom:-1px}.DnJfK{position:relative}.l97dzf{font-weight:400}.zBAuLc{line-height:normal;margin:0;padding:0}.BNeawe{white-space:pre-line;word-wrap:break-word}.vvjwJb{color:#1a0dab;font-size:20px;line-height:26px}a:visited .vvjwJb,.vvjwJb a:visited{color:#4b11a8}.vvjwJb.HrGdeb{color:#fff}a:visited .vvjwJb.HrGdeb,.vvjwJb.HrGdeb a:visited{color:rgba(255,255,255,.70)}.UwRFLe{display:-webkit-box;-webkit-box-orient:vertical;overflow:hidden}.UPmit{font-size:14px;line-height:22px}.UPmit.HrGdeb{color:rgba(255,255,255,.70)}.UPmit.AP7Wnd{color:#202124}.lRVwie{text-overflow:ellipsis;white-space:nowrap;overflow:hidden}.Ap5OSd{padding-bottom:12px}.s3v9rd{font-size:14px;line-height:22px}.s3v9rd.HrGdeb{color:#fff}.s3v9rd.AP7Wnd{color:#202124}.mSx1Ee{padding-left:48px;margin:0}.v9i61e{padding-bottom:8px}.U8ml0d{text-decoration:line-through}.XLloXe{color:#1a0dab;font-size:14px;line-height:20px}a:visited .XLloXe,.XLloXe a:visited{color:#4b11a8}.XLloXe.HrGdeb{color:#fff}a:visited .XLloXe.HrGdeb,.XLloXe.HrGdeb a:visited{color:rgba(255,255,255,.70)}.r0bn4c.tr0dw{color:rgba(255,255,255,.70)}.r0bn4c.rQMQod{color:#70757a}.K8tyEc{padding-bottom:12px}.mEUgP{font-size:20px;font-weight:bold;line-height:26px;color:#1f1f1f;height:14px;padding:16px 14px 0px 14px;margin:0}.iIWm4b{box-sizing:border-box;min-height:48px}.gGQDvd{position:relative;padding:20px 14px 14px 14px;height:60px;}.Q71vJc{display:block;position:relative;width:100%}.kjGX2{position:absolute;vertical-align:bottom;display:inline-block;right:48px;left:0;color:#4d5156;}.Xe4YD{font-size:16px}.ieB2Dd{overflow:hidden;margin-top:-10px;margin-bottom:-16px;margin-right:8px;border-radius:4px;display:inline-block;border-radius:50%;padding:8px 7px 8px 9px;background-color:#f7f8f9;}.toMBf{position:absolute;right:0;margin-right:-8px;margin-top:-2px}.d9dqO{flex:none}.z1asCe{display:inline-block;fill:currentColor;height:24px;line-height:24px;position:relative;width:24px}.z1asCe svg{display:block;height:100%;width:100%}.C5GhQc{color:rgba(0,0,0,.54);}.x54gtf{height:1px;background-color:#dadce0;margin:0 14px}.Q0HXG{height:1px;background-color:#dadce0;}.rLshyf,.BmP5tf{padding-top:16px;padding-bottom:12px}.YOx3Ab{padding-left:14px;}.w1C3Le,.BmP5tf,.G5NbBd,.CS4w5b{padding-left:14px;padding-right:14px;}.G5NbBd{padding-bottom:12px}.CS4w5b{padding-top:12px}.nMymef{display:flex}.G5eFlf{flex:1;display:block}.nMymef span{text-align:center}.EYqSq{margin:6px 4px 9px 0;border-radius:100%;display:inline-block;height:10px;vertical-align:middle;width:10px}.dfB0uf{color:#3c4043;font-weight:bold}.IffyKc{word-wrap:break-word}
   </style>
   <div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAMQAg" href="/url?q=https://www.sec.gov/Archives/edgar/data/732485/000091205702012898/a2073695z10-k.htm&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAMQAg&amp;usg=AOvVaw2d-ATq02VnwLwznnihnl6T">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           genzyme corporation - SEC.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sec.gov › Archives › edgar › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           We are a biotechnology and human healthcare company that develops innovative products and provides services for major unmet medical needs. We were founded as a ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            independently
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIAxAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+that+operates+%22independently%22+or+under+Genzyme's+control?&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIAxAF">
             <span class="XLloXe AP7Wnd">
              independently
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECGQQAg" href="/url?q=https://investors.vcel.com/static-files/0319757e-09b1-44b8-b852-32bf1a60fa3f&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECGQQAg&amp;usg=AOvVaw3X-4kKdLRmjvJKkYUQeu8t">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Aastrom Biosciences, Inc. - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.vcel.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           The acquisition of Biosurface Technologies Corporation in 1994 brought both Carticel and Epicel to Genzyme ... operated as a stand-alone entity. Inventories.
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            independently
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIZBAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+that+operates+%22independently%22+or+under+Genzyme's+control?&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIZBAF">
             <span class="XLloXe AP7Wnd">
              independently
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECGMQAg" href="/url?q=https://www.sanofi.com/assets/dotcom/content-app/publications/annual-report-on-form-20-f/2014-01-01-form-20-f-2014-en.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECGMQAg&amp;usg=AOvVaw2-DzMPPWnmlCH9qAjwZCMv">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] FORM 20-F 2014 | Sanofi
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sanofi.com › publications › 2014-01-01-form-20-f-2014-en
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2013
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Yes. No . Page 3. PRESENTATION OF FINANCIAL AND OTHER INFORMATION. The consolidated financial statements contained in this annual report ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECGIQAg" href="/url?q=https://investors.biogen.com/static-files/bd764222-feb6-4b8b-a443-bc0da4bdcd53&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECGIQAg&amp;usg=AOvVaw3jRZaqUofxjnJchkIQ8R2T">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] biogen idec inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.biogen.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           We collaborate with Genentech Inc., or Genentech, on the development and commercialization of RITUXAN. ... control of confidential information and personal ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Focal,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIYhAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+%22Focal,%22+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme's+control?&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIYhAF">
             <span class="XLloXe AP7Wnd">
              Focal,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECGEQAg" href="/url?q=http://getfilings.com/o0000912057-01-506403.html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECGEQAg&amp;usg=AOvVaw0A25jRZD0aIQHfSbxIov4_">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GENZYME CORP - 10-K Annual Report - 12/31/2000 - Get Filings
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          getfilings.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           - Genzyme Molecular Oncology Division = "Genzyme Molecular Oncology." ... this Annual Report on Form 10-K. Please read that information. ... Epicel-Registered ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            independently
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIYRAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+that+operates+%22independently%22+or+under+Genzyme's+control?&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIYRAF">
             <span class="XLloXe AP7Wnd">
              independently
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECGAQAg" href="/url?q=https://www.sec.gov/Archives/edgar/data/28626/000091205700041589/a2025741z10-k.htm&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECGAQAg&amp;usg=AOvVaw33RxVjUIZyLtGBOJSDRm52">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Prepared by MERRILL CORPORATION www.edgaradvantage.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sec.gov › Archives › edgar › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Lifecore Biomedical, Inc. ("Lifecore" or the "Company") develops, manufactures, and markets biomaterials and surgical devices through two divisions, the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECF4QAg" href="/url?q=https://ir.voyagertherapeutics.com/node/7451/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECF4QAg&amp;usg=AOvVaw1jPuUcEY3RFB-ZplgRf7ve">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Voyager Therapeutics Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.voyagertherapeutics.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Following Genzyme's exercise of an option for a program, Genzyme will have sole responsibility for the development and commercialization of the product ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECF0QAg" href="/url?q=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340106/&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECF0QAg&amp;usg=AOvVaw3cMiBGXrb0t4SLM7leB4jY">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Imiglucerase in the treatment of Gaucher disease: a history and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ncbi.nlm.nih.gov › pmc › articles › PMC3340106
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 18, 2012
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... billion. The Genzyme Corporation is now a wholly owned subsidiary of Sanofi SA. Sanofi SA is headquartered in Paris: it has activities in ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            operates
           </span>
           <span class="U8ml0d rQMQod">
            independently
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECF8QAg" href="/url?q=https://synapse.patsnap.com/organization/bbc5fe68369d38a0223445bb4a014033&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECF8QAg&amp;usg=AOvVaw1Qq9CcdDG8oJ8_fUKQ7jjq">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Genzyme Corp. - Drug pipelines, Patents, Clinical trials - Synapse
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          synapse.patsnap.com › organization
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           The company is committed to discovering and advancing new therapies to provide hope to patients and their families worldwide. Genzyme became a part of Sanofi in ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            independently
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIXxAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+that+operates+%22independently%22+or+under+Genzyme's+control?&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIXxAF">
             <span class="XLloXe AP7Wnd">
              independently
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFwQAg" href="/url?q=https://ir.teknova.com/static-files/b6aaf661-6385-4695-953a-eb5e6fd0322e&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFwQAg&amp;usg=AOvVaw2sd2WFmSyztZ7pVdR2blrA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Alpha Teknova, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.teknova.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... UNDER. THE SECURITIES ACT OF 1933. ALPHA TEKNOVA, INC. (Exact name of Registrant as specified in its charter). Delaware, 8731. 94-3368109. (State or other ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFoQAg" href="/url?q=https://investors.vcel.com/node/16061/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFoQAg&amp;usg=AOvVaw1mUb1vsA82DBVPV3UW7zrf">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Investor Relations - Vericel Corporation
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.vcel.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           MACI was obtained via the acquisition by Genzyme Corporation, a subsidiary of Sanofi, of Verigen AG (Verigen) in 2005. As part of its acquisition of Verigen, ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFkQAg" href="/url?q=https://www.sanofi.com/assets/dotcom/content-app/publications/annual-report-on-form-20-f/2015-01-01-form-20-f-2015-en.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFkQAg&amp;usg=AOvVaw1hA4vw-ahZcKD4kLZXF0Ea">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Forms 20-F 2015 - Sanofi
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sanofi.com › publications › 2015-01-01-form-20-f-2015-en
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jan 1, 2015
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           other countries in which we operate. This information is based on data, assumptions and estimates considered as reasonable by the Company as ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFsQAg" href="/url?q=https://www.sciencedirect.com/science/article/am/pii/S0048733321000214&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFsQAg&amp;usg=AOvVaw01pW5wkUYJ2ob96mYVh6_z">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Matching patents to compustat firms, 1980–2015 - ScienceDirect.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sciencedirect.com › science › article › pii
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 7, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           years when GENZYME TRANSGENICS CORP falls under GENZYME CORP and ... but it is included as a subsidiary name under the Time-Warner UO company.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFgQAg" href="/url?q=https://www.annualreports.com/HostedData/AnnualReportArchive/c/NASDAQ_CBMG_2013.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFgQAg&amp;usg=AOvVaw2xQV39Xy_1-ijjcGa8EuHd">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Cellular Biomedicine Group, Inc. - AnnualReports.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.annualreports.com › HostedData › NASDAQ_CBMG_2013
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 15, 2014
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           CBMG BVI, our primary operating subsidiary, focuses on ... We are currently structured as a U.S. corporation (Delaware) with subsidiaries and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFcQAg" href="/url?q=http://getfilings.com/o0000912057-00-014941.html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFcQAg&amp;usg=AOvVaw0Xb3kwzWz7Q0JSH23CNgsH">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GENZYME CORP - 10-K Annual Report - 12/31/1999 - Get Filings
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          getfilings.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           under the heading "Management's Discussion and Analysis of Genzyme Corporation and Subsidiaries' Financial Condition and Results of Operations" and in Note Q.,
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFYQAg" href="/url?q=https://synapse-patsnap-com.libproxy1.nus.edu.sg/organization/bbc5fe68369d38a0223445bb4a014033&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFYQAg&amp;usg=AOvVaw35CVo-Ce-SsDtqGzIySf4E">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Genzyme Corp. - Drug pipelines, Patents, Clinical trials - Synapse
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          synapse-patsnap-com.libproxy1.nus.edu.sg › organization
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           Genzyme became a part of Sanofi in 2011 and has since expanded its focus to include multiple sclerosis, oncology, and immunology. Their approach is shaped by a ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            independently
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIVhAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+that+operates+%22independently%22+or+under+Genzyme's+control?&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIVhAF">
             <span class="XLloXe AP7Wnd">
              independently
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFMQAg" href="/url?q=https://assets.aeaweb.org/asset-server/files/13979.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFMQAg&amp;usg=AOvVaw0zhAvRKBqf_wUX8nzgfOpy">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Online Appendix for “Knowledge spillovers and corporate ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          assets.aeaweb.org › asset-server › files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... in our sample that earlier data missed because the focal firm operated under a ... but it is included as a subsidiary name under the Time-Warner UO company.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFIQAg" href="/url?q=https://ir.travere.com/node/7896/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFIQAg&amp;usg=AOvVaw2qKCxZpk_nab-4Wuj23d7q">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing ID 0001193805-13-001119 - Travere Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.travere.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... subsidiary and the principal operating subsidiary of the Company. The ... Any inability on the part of our management to manage growth could delay the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFUQAg" href="/url?q=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157570/&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFUQAg&amp;usg=AOvVaw0uHPhCQwC0fp3xa1DUq8nj">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           A comparison of clinically utilized human papillomavirus detection ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ncbi.nlm.nih.gov › pmc › articles › PMC3157570
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 13, 2011
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... subsidiary of LabCorp, under license. Esoterix Genetic Laboratories and LabCorp are operated independently from Genzyme Corporation. Go to ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFQQAg" href="/url?q=https://investors.biogen.com/static-files/12f43b1c-c17c-41f7-a9a2-714dd76155d4&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFQQAg&amp;usg=AOvVaw22wyZkZ00xhVuNidoEIrTH">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Download PDF - Biogen | Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.biogen.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           subsidiaries) or, in certain cases, Biogen Idec Inc., was named as a ... change in control in our company occurs on or before April 29, 2007, holders ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Focal,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIVBAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+%22Focal,%22+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme's+control?&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIVBAF">
             <span class="XLloXe AP7Wnd">
              Focal,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFEQAg" href="/url?q=https://ir.mallinckrodt.com/static-files/b243f547-5502-46f6-a745-81bd18cd8ec6&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFEQAg&amp;usg=AOvVaw0yeZjP_LuBrctwIry_rObG">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Questcor Pharmaceuticals, Inc. - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.mallinckrodt.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We intend to have BioVectra continue to operate independently under its ... out in Section 4.43 of the Disclosure Letter on the part of the Company or any of the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFAQAg" href="/url?q=https://investors.bellerophon.com/node/7366/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECFAQAg&amp;usg=AOvVaw37hUg17uImkYAKKhApXuAO">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Investors | Bellerophon Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.bellerophon.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Unit are immediately separable and will be issued separately in this offering. ... Neither the Company nor any Subsidiary: (i) is in default under or in ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECE8QAg" href="/url?q=https://public4.pagefreezer.com/content/FDA/21-03-2024T11:23/https://www.fda.gov/media/164573/download%3Fattachment&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECE8QAg&amp;usg=AOvVaw1yTiRsbKn9vOEm3Vi9zIsM">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [XLS] queryResult - Pagefreezer
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          public4.pagefreezer.com › https: › www.fda.gov › media › download
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... in India. 3294, 2019-764, 02/04/2019, IZI Medical Products, LLC, K150523. 3295, 2019-765, 02/04/2019, Davol, Inc., subsidiary of C. R. Bard, Inc. P170012. 3296 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECE4QAg" href="/url?q=https://www.ctad-alzheimer.com/files/files/CTAD%2520ABSTRACT%25202023%2520%2528V2%2529.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECE4QAg&amp;usg=AOvVaw2eXGESHQwrakiOvxSuaRol">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 16th Clinical Trials on Alzheimer's Disease (CTAD)
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ctad-alzheimer.com › files › files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... control group, when available. The MMRM incorporated fixed effects such as baseline value, treatment arm, visit, and their respective interactions. All ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECE0QAg" href="/url?q=https://journals.lww.com/kidney360/fulltext/2024/04000/all_patients_with_adpkd_should_undergo_screening.4.aspx&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECE0QAg&amp;usg=AOvVaw2CZQvktL10O0H4b0T1XiHB">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           All Patients with ADPKD Should Undergo Screening for Intracranial ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          journals.lww.com › kidney360 › fulltext › all_patients_with_adpkd_should...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Given the increased prevalence of intracranial aneurysms (ICAs) in patients with autosomal dominant polycystic kidney disease (ADPKD) and their potentially ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEwQAg" href="/url?q=https://ir.biohaven.com/static-files/003e3e19-c990-43d0-bfcd-d2b7ce91ea51&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEwQAg&amp;usg=AOvVaw0oXFflp6zAw4zQhqOQQy2j">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form DEF 14A for Biohaven LTD filed 03/18/2024
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.biohaven.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 18, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           On this record date, there were 81,596,082 common shares outstanding, each of which is entitled to one vote per share. Each common share confers ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEoQAg" href="/url?q=http://ir.scpharma.com/node/6641/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEoQAg&amp;usg=AOvVaw2bxgpDaF4PLtns7cpfHCBm">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | scPharmaceuticals, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.scpharma.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEsQAg" href="/url?q=https://www.hrsa.gov/sites/default/files/hrsa/opa/orphan-drug-list-october-1-december-31-2022.xlsx&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEsQAg&amp;usg=AOvVaw011kT0McCyNPv8R9WGt45k">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [XLS] Orphan Drug List Governing January 1 to March 31, 2019 - HRSA
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.hrsa.gov › opa › orphan-drug-list-october-1-december-31-2022
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Viracta Subsidiary, Inc. 30, 29, O-(2-[18F]fluoroethyl)-L-tyrosine, 10/05/2020, Diagnostic for the management of glioma, Telix Pharmaceuticals Limited (Telix).
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEkQAg" href="/url?q=https://investors.embecta.com/static-files/2f2dd286-63f8-403b-a25a-a4c995d6e67c&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEkQAg&amp;usg=AOvVaw2DWmiP2nk9i4SepQMnrGyV">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 2024 Notice of Annual Meeting and Proxy Statement
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.embecta.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 19, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           connection with the Separation and listing as an independent public company in 2022, the ... management deems irregular or non-operating in ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEgQAg" href="/url?q=http://ndl.ethernet.edu.et/bitstream/123456789/87807/5/Strategic%2520Management%2520of%2520Technological%2520Innovation%252C%2520Fourth%2520Edition%2520%2528%2520PDFDrive.com%2520%2529.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEgQAg&amp;usg=AOvVaw2jkdE1j0l94cBXRzm8u5IK">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Strategic Management of Technological Innovation, Fourth Edition
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ndl.ethernet.edu.et › bitstream
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Inc., 1221 Avenue of the Americas,. New York, NY, 10020 ... The outline of the book is designed to mirror the strategic management process used in.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEcQAg" href="/url?q=https://www.healthadvantage-hmo.com/docs/librariesprovider6/default-document-library/ha-provider-manual.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEcQAg&amp;usg=AOvVaw1DhrZHhCESN4U68G6aQ7tt">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Provider Manual | Health Advantage
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.healthadvantage-hmo.com › docs › default-document-library
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The focal point of case management in all of its roles is to empower ... The Employee Benefits Division (EBD) and Health Advantage, a subsidiary company of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEYQAg" href="/url?q=https://pages.cs.wisc.edu/~ramak/rawork/TPC-E/EGen_v3.14/flat_in/Company.txt&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEYQAg&amp;usg=AOvVaw3GSFZFiliFoiTk6BuiQX4X">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Company.txt - cs.wisc.edu
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          pages.cs.wisc.edu › ~ramak › rawork › TPC-E › EGen_v3.14 › flat_in › C...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... operates six branch banking offi 6 ACTV 99 Cents Only Stores RL 99 Cents ... under three segments namely: commercial &amp; con 26 ACTV A. Schulman, Inc. FR ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEUQAg" href="/url?q=https://www.cambridgema.gov/~/media/Files/budgetdepartment/citybondsale/Cambridge%2520PRELIM_2%252013%252013_1.ashx&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEUQAg&amp;usg=AOvVaw0yK4DaGa16EH9d05mqwG9T">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] UBS Financial Services Inc. - the City of Cambridge
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cambridgema.gov › Files › budgetdepartment › citybondsale
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 15, 2013
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The City operates under the Council-Manager form of government. The legislature and policy making body of the City is the nine-member City ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEMQAg" href="/url?q=https://ir.aerovatetx.com/static-files/299c62b1-192e-4502-b9aa-0253d75b353c&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEMQAg&amp;usg=AOvVaw38rfXp7gGwxqG3pBYuQRk8">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] 0001104659-21-084790.rtf - Aerovate Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.aerovatetx.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Under. The Securities Act of 1933. AEROVATE THERAPEUTICS, INC. (Exact name of registrant as specified in its charter). Delaware, 2834. 83-1377888. (State or ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEIQAg" href="/url?q=https://www.macomptroller.org/wp-content/uploads/acfr_fy-2008.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEIQAg&amp;usg=AOvVaw112Mzpx1gQ3LnWg8IEkLhi">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Commonwealth of Massachusetts Comprehensive Annual Financial ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.macomptroller.org › wp-content › uploads › acfr_fy-2008
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           debt, this limit provides a control on annual capital spending. The direct ... profit subsidiary, the Worcester Foundation for Biomedical Research, Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEEQAg" href="/url?q=https://ir.exelixis.com/static-files/21cddf02-e799-43f7-ba64-227bb1dddfe2&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEEQAg&amp;usg=AOvVaw24a18XInJWSFkk6TEXYmik">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form 10-K for Exelixis INC filed 02/06/2024
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.exelixis.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 27, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Independent Registered Public Accoun ng Firm are included in Part II, Item 8: ... in Control, “Company” shall mean only Exelixis, Inc. or ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEQQAg" href="/url?q=https://www.sciencedirect.com/topics/economics-econometrics-and-finance/strategic-business-unit&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEQQAg&amp;usg=AOvVaw1Sy4I8wxNUrBR9Ih6zMSOY">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Strategic Business Unit - an overview | ScienceDirect Topics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sciencedirect.com › topics › economics-econometrics-and-finance › s...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           ... management, which may be considered another major sub-function. Finally, direct trading by the market management company on its own behalf may be seen as ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Inc.
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIRBAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+%22Inc.%22+a+subsidiary+that+operates+independently+or+under+Genzyme's+control?&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5t4CegQIRBAF">
             <span class="XLloXe AP7Wnd">
              Inc.
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEAQAg" href="/url?q=https://investor.bluebirdbio.com/static-files/600b5870-ec4b-4bc6-aaa5-cf967d10a115&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECEAQAg&amp;usg=AOvVaw130uopcRIii55RVu-ANvM6">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] bluebird bio, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.bluebirdbio.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... in control of our company and might harm the market price of our common stock ... The Company leases office space under non-cancelable operating leases.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECD8QAg" href="/url?q=https://investors.medicinova.com/node/12096/ixbrl-viewer&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECD8QAg&amp;usg=AOvVaw0TaaN5ShSK0uWaupiTi_Dk">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           0001564590-21-006771 | 10-K | iXBRL Viewer - MediciNova, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.medicinova.com › node › ixbrl-viewer
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We initiated a clinical trial of MN-166 (ibudilast) in amyotrophic lateral sclerosis (ALS) in the second half of 2014, and this trial was completed during the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECD4QAg" href="/url?q=https://evp.harvard.edu/files/evp/files/deir_web_1220131.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECD4QAg&amp;usg=AOvVaw0liT2pnP_MVAe88y5i8cGX">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] DRAFT ENVIRONMENTAL IMPACT REPORT
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          evp.harvard.edu › files › evp › files › deir_web_1220131
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Inc. Page 4. Page 5. i. Harvard ... For those projects that are adequately described in the Draft and Final EIR no further review under MEPA is required.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECD0QAg" href="/url?q=https://investors.artivion.com/static-files/4a3bff84-22f2-4107-945f-989c824c17b9&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECD0QAg&amp;usg=AOvVaw35nrdh4s5Vx7HpPmBkWD99">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [RTF] 0000914062-01-500169.rtf - Investor Overview
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.artivion.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           investment in its wholly-owned subsidiary company, AuraZyme Pharmaceuticals,. Inc. ("AuraZyme"), for the commercial development of its Activation Control.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDsQAg" href="/url?q=https://www.cms.gov/files/document/open-payments-fy-2022-report-congress.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDsQAg&amp;usg=AOvVaw0gStMaVxi6_DbUSyKDFtTF">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Fiscal Year 2022 Annual Report on the Open Payments Program
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cms.gov › files › document › open-payments-fy-2022-report-co...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Focal Therapeutics, Inc. $69,760.04. $0.00. $0.00. $0.00. 45. 0. 0. 0. 40. 0. 1. Fones Marketing Management, Inc. ... NeuroLogica Corporation, a subsidiary of.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDwQAg" href="/url?q=https://investors.ascendispharma.com/static-files/76fa5ef4-190d-43bc-8bf4-eb794a629e7a&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDwQAg&amp;usg=AOvVaw3kn8NyKLCg0buPWSkUu69s">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Ascendis Pharma A/S
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.ascendispharma.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... independently conduct clinical trials or IND-enabling nonclinical studies ... in existing systems and controls. Our management, personnel, systems and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDgQAg" href="/url?q=https://ir.travere.com/node/8136/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDgQAg&amp;usg=AOvVaw0vprIKUmny8Uu4QFl6s7Dn">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Travere Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.travere.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDoQAg" href="/url?q=https://investors.tenayatherapeutics.com/node/6351/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDoQAg&amp;usg=AOvVaw3J81wzox2a79lud7undPJm">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Tenaya Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.tenayatherapeutics.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Heart value disease occurs when there is a problem with one or more of the four valves that normally work in unison to make sure that blood is pumped in the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDkQAg" href="/url?q=https://asset.researchtopractice.com/2022/Meetings/Asco/ASCO22_Myeloma.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDkQAg&amp;usg=AOvVaw3GwgJ-RugF3k5HLEc7suM8">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Breakfast with the Investigators: Multiple Myeloma
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          asset.researchtopractice.com › Meetings › Asco › ASCO22_Myeloma
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 7, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Pharmaceuticals Inc, Sanofi Genzyme, Seagen Inc, Servier ... Amgen Inc, Array BioPharma Inc, a subsidiary of Pfizer Inc, Celgene.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDcQAg" href="/url?q=https://www.cshl.edu/wp-content/uploads/2022/11/CSHL_AR_2003.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDcQAg&amp;usg=AOvVaw3Kfja03BvyUET8XiwmJ9Rx">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Untitled - Cold Spring Harbor Laboratory
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cshl.edu › wp-content › uploads › 2022/11 › CSHL_AR_2003
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Inc. Eduardo G. Mestre. Chairman, Investment ... It is authorized to operate a graduate program under ... control a wide variety of impor- tant biological ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDYQAg" href="/url?q=https://www.modernpathology.org/article/S0893-3952(22)01793-8/fulltext&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDYQAg&amp;usg=AOvVaw03DicH_Fq-OwQOuF4NCqcz">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           A comparison of clinically utilized human papillomavirus detection ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.modernpathology.org › article › fulltext
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           In addition, control ... subsidiary of LabCorp, under license. Esoterix Genetic Laboratories and LabCorp are operated independently from Genzyme Corporation.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDUQAg" href="/url?q=https://investors.praxismedicines.com/static-files/4665af89-afc8-4fb7-90bb-b9a98b983bfc&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDUQAg&amp;usg=AOvVaw1LnbST4knxQRADVqdfySwD">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form DEF 14A for Praxis Precision Medicines INC filed 04/28/2023
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.praxismedicines.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 28, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... company which is material to that director's ability to be independent from management in connection with the duties of a compensation ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDQQAg" href="/url?q=https://investor.arbutusbio.com/node/14821/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDQQAg&amp;usg=AOvVaw2MhD3pfvO84P2AAnmPKlt-">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Arbutus Biopharma Corporation
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.arbutusbio.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Proposal No. 2: To approve the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDMQAg" href="/url?q=https://investors.atyrpharma.com/node/6736/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDMQAg&amp;usg=AOvVaw1XuROOzpeXmRbToOVjXCk4">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | aTyr Pharma
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.atyrpharma.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           This is the initial public offering of shares of common stock of aTyr Pharma, Inc. We are offering shares to be sold in this offering. Prior to this offering, ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDIQAg" href="/url?q=https://esd.ny.gov/sites/default/files/news-articles/32918-ESD-Posting-Materials.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDIQAg&amp;usg=AOvVaw2Nmg4Treo9ycT3D6tCOiSK">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] NYS Urban Development Corporation Meeting
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          esd.ny.gov › sites › files › news-articles › 32918-ESD-Posting-Materials
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 29, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           All subsidiary operating and capital budgets must also be presented separately to and approved by their respective Boards within the same ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDAQAg" href="/url?q=https://www.dealpointdata.com/rj%3Fvb%3DAction.downloadPDF%26app%3Dcorp%26id%3D000193597924000026_bhvn-20240314htm&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDAQAg&amp;usg=AOvVaw1wnvHh-dZU7atPgAkDW13I">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Biohaven Ltd. - Deal Point Data
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.dealpointdata.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 18, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... management's actions are in the best interests of the Company and our shareholders. ... December 31, 2023, under Part I, Item 1A. Risk ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECC4QAg" href="/url?q=https://www.gibsondunn.com/2015-year-end-fda-and-health-care-compliance-and-enforcement-update-drugs-and-devices/&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECC4QAg&amp;usg=AOvVaw3lpwLSq8BEm3ZreoGniUKv">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           2015 Year-End FDA and Health Care Compliance and Enforcement ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.gibsondunn.com › 2015-year-end-fda-and-health-care-compliance-a...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jan 19, 2016
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           In September 2015, Genzyme Corporation, a wholly owned biotechnology subsidiary ... control the administration of medication through the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECC8QAg" href="/url?q=https://ir.biolinerx.com/static-files/bc494bca-d27a-4515-9bd5-0c09ec77b5b8&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECC8QAg&amp;usg=AOvVaw3LQ3VEV39pOqO0r-fA8tX9">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] BioLineRx Ltd.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.biolinerx.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 6, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           indirect benefit by the company, its controlling shareholder or any entity under ... operating effectiveness of internal control based on the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDEQAg" href="/url?q=https://www.journals.uchicago.edu/doi/10.1086/421508&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECDEQAg&amp;usg=AOvVaw1PtQabFeTNM4gSUoxjAGRB">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Network Dynamics and Field Evolution: The Growth of ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.journals.uchicago.edu › doi
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... control, such as an equity stake or dominance on the board of directors. We turn ... company's stock continues to be independently traded. We exclude ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECC0QAg" href="/url?q=https://www.auriniapharma.com/investors-and-media/sec-filings/all-sec-filings/content/0001628280-18-003228/exhibit991-aif.htm&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECC0QAg&amp;usg=AOvVaw3H-2Dh8XNSmKqiwCGfti3P">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Exhibit - Aurinia Pharmaceuticals
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.auriniapharma.com › all-sec-filings › content › exhibit991-aif
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The AURORA clinical trial is a global 52-week double-blind, placebo-controlled study of approximately 320 patients to evaluate whether voclosporin added to ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCwQAg" href="/url?q=https://investors.cerevel.com/node/7626/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCwQAg&amp;usg=AOvVaw2FLyasSbuKx-XhWgSd3a32">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Pfizer license agreement - SEC Filing | Cerevel Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.cerevel.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We are a clinical-stage biopharmaceutical company with a limited operating history. We have incurred significant financial losses since our inception and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCsQAg" href="/url?q=https://www.crowell.com/a/web/fjE8bDx37ZQcEhPo1FV5KT/4Ttk77/dc-focus-the-city-the-law-the-lawyers.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCsQAg&amp;usg=AOvVaw10wUUxWSZB1fRqo0ZPWXnB">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] The city. The law. The lawyers. - Crowell &amp; Moring LLP
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.crowell.com › web › dc-focus-the-city-the-law-the-lawyers
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           operating on a global scale face challenges with export control and ... company in a major internal review of sanctions compliance triggered by enforcement ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCoQAg" href="/url?q=https://www.fdanews.com/ext/resources/files/archives/1/10/100410_IOM_Report.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCoQAg&amp;usg=AOvVaw0hEhJJUfDGfG2MD1dH8D4N">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Rare Diseases and Orphan Products: Accelerating Research and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.fdanews.com › ext › files › archives › 100410_IOM_Report
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           and management guidelines based in part on national registry data analyses. ... For example, the company Spiration, Inc., received HDE approval for a device to ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCkQAg" href="/url?q=https://journals.lww.com/cjasn/fulltext/2022/10000/perspectives_on_drug_development_in_autosomal.19.aspx&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCkQAg&amp;usg=AOvVaw3nKCPTZ6gSi8oFCrUiGU9W">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Perspectives on Drug Development in Autosomal Recessive Poly...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          journals.lww.com › cjasn › fulltext › perspectives_on_drug_development_i...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Lessons learned from autosomal dominant polycystic kidney disease (ADPKD) will strongly influence ARPKD drug development. ARPKD is mainly caused by variants in ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCcQAg" href="/url?q=https://europepmc.org/article/med/21572401&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCcQAg&amp;usg=AOvVaw2eET-sbrNuvOe7oe0kFb0s">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           A comparison of clinically utilized human papillomavirus detection ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          europepmc.org › article › med
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... subsidiary of LabCorp, under license. Esoterix Genetic Laboratories and LabCorp are operated independently from Genzyme Corporation. Go to: References. 1 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCYQAg" href="/url?q=https://www.aetna.com/cpb/medical/data/200_299/0244.html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCYQAg&amp;usg=AOvVaw0Tqd1rTk_X16begCNG0bYI">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Skin and Soft Tissue Substitutes - Medical Clinical Policy Bulletins
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.aetna.com › cpb › medical › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           each additional 25 cc injectate, or part thereof (List separately in addition to code for primary procedure) ... AmnioArmor (Bone Bank Allografts, a subsidiary of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCgQAg" href="/url?q=https://ir.biohaven.com/static-files/e8b390f1-a1db-410e-9ce4-3ce91eb38fb0&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCgQAg&amp;usg=AOvVaw3-OMyLysJW9Z0KOvxtU_FA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] biohaven ltd.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.biohaven.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           setting the compensation of our other executive officers, based in part on recommendations of the chief executive officer; ... in Control. Employment Agreements ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCUQAg" href="/url?q=https://ir.fulcrumtx.com/node/7001/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCUQAg&amp;usg=AOvVaw3Dq-TFOImeLUCYB4OzwTwX">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Investor Relations - Fulcrum Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.fulcrumtx.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Prior to that, he served in various senior management roles at Genzyme Corporation ... controls or manages, or is under common control with, the signatory;.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCQQAg" href="/url?q=https://louisville.edu/medicine/departments/pediatrics/research/research-bios/janice-e-sullivan-md-cv&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCQQAg&amp;usg=AOvVaw2sDS80T7rwtRZgmrZEFA4J">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Janice E. Sullivan, MD 24 JUL 2021 Page 2 - University of Louisville
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          louisville.edu › departments › pediatrics › research › research-bios › j...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jul 24, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Merck Sharp &amp; Dohme Corp., (a subsidiary of Merck &amp; Co. Inc ... Glycemic Control on Metformin Monotherapy”, Merck Sharp &amp; Dohme Corp ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCMQAg" href="/url?q=https://jamanetwork.com/journals/jamaneurology/fullarticle/1389385&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCMQAg&amp;usg=AOvVaw1JqXzAV1KohzfZUs36un9L">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Natalizumab: Bench to Bedside and Beyond - JAMA Network
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          jamanetwork.com › journals › jamaneurology › fullarticle
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 5, 2012
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Operating independently at first but later acquired by Elan Corporation (in 1996) as a wholly owned subsidiary, Athena Neurosciences ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCIQAg" href="/url?q=https://investors.vrtx.com/static-files/281eaa29-0e92-4113-8286-7c85d9bbb748&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCIQAg&amp;usg=AOvVaw0JpiqXUcjSJzO6RUs14VCd">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Download DOC - Investor Relations | Vertex Pharmaceuticals
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.vrtx.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... INCORPORATED. ANNUAL REPORT ON FORM 10-K. TABLE OF CONTENTS. PART I. Item 1 ... Incorporated, a Massachusetts corporation, and its subsidiaries. “VERTEX ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECB8QAg" href="/url?q=https://www.congress.gov/109/chrg/shrg30085/CHRG-109shrg30085.htm&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECB8QAg&amp;usg=AOvVaw0ZcF7C7RdDjcdmbTeqKQXO">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           - NOMINATION OF ANDREW VON ESCHENBACH and PAUL ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.congress.gov › chrg › shrg30085
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... under which it operates and the science before it. Recent survey of the ... Plan B contains the same ingredient used in prescription birth control pills, only in ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECB0QAg" href="/url?q=https://www.bayer.com/sites/default/files/2020-05/ar-2016.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECB0QAg&amp;usg=AOvVaw02PIkTdukAj90PQcT83O92">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Annual Report - Bayer
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bayer.com › sites › default › files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... control her allergy symptoms. “Then I started using Claritin™. It's exactly ... Inc. in Princeton. In 2014, Weinand became head of the Pharmaceuticals ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECB4QAg" href="/url?q=https://investors.generationbio.com/node/6616/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECB4QAg&amp;usg=AOvVaw0Y2dl3yBlJZIbmUFCikieF">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Investor Relations - Generation Bio
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.generationbio.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We are an emerging growth company as that term is used in the Jumpstart Our Business Startups Act of 2012 and, as such, have elected to comply with certain ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCAQAg" href="/url?q=https://ir.microbotmedical.com/node/7866/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCAQAg&amp;usg=AOvVaw3q45NpM4t11_BxqLroa4fS">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Microbot Medical Inc
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.microbotmedical.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           In July 1999 we began restructuring the company to focus solely on our stem cell technology. As part of this restructuring we terminated all activities related ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBwQAg" href="/url?q=https://jnm.snmjournals.org/content/jnumed/63/2/local/complete-issue.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBwQAg&amp;usg=AOvVaw0vUtrQsO2kFpDiC8Nfanup">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Complete Issue (PDF) - Journal of Nuclear Medicine
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          jnm.snmjournals.org › content › jnumed › local › complete-issue
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 9, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Formed in 2014, the company's success is driven by its management ... The costs of publication of all nonsolicited articles in JNM were defrayed ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCEQAg" href="/url?q=https://www.sekisuichemical.com/ir/report/annual/pdf/SC_IR2022_ALL_E.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECCEQAg&amp;usg=AOvVaw2EbmDPkgwifbFnBKff5dwv">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Integrated Report 2022 - Sekisui Chemical
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sekisuichemical.com › annual › pdf › SC_IR2022_ALL_E
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The same is true of business. Only when employees mass under a common ideal arising from a basic policy of business management can the company demonstrate its ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBsQAg" href="/url?q=https://www.humanservices.state.pa.us/PROVIDER_REIMBURSEMENT&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBsQAg&amp;usg=AOvVaw14RNEcHj9wrHM16yRWN4Lo">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Search Provider Page Human Services Facilities
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.humanservices.state.pa.us › PROVIDER_REIMBURSEMENT
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Reimbursement amounts returned by Provider Name should match the amount reported to payees on their 1099-MISC, Miscellaneous Income, for the payment year (or ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBoQAg" href="/url?q=https://materials.proxyvote.com/Approved/74006W/20230417/NPS_539473.PDF&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBoQAg&amp;usg=AOvVaw2BDLdDgs05OTb5AdsE4P7n">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] PRAX - 2023 DEF14A - A Service From Broadridge
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          materials.proxyvote.com › Approved › NPS_539473
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 28, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Committee operates under ... the oversight of our company and active participation of the independent directors in setting agendas and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBgQAg" href="/url?q=https://investors.verisresidential.com/sec-filings/all-sec-filings/content/0000912057-00-008151/10-K405.txt&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBgQAg&amp;usg=AOvVaw0feuX9eTf4noZyo6zfuVdi">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           10-K405 Filing - Veris Residential, Inc. (VRE)
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.verisresidential.com › sec-filings › all-sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           LOCATION OF EXHIBIT INDEX: The index of exhibits is contained in Part IV herein on page number 61. ... alone retail properties as of December 31, 1999, described ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBkQAg" href="/url?q=https://www.pieris.com/investors/sec-filings/all-sec-filings/content/0001583648-19-000011/0001583648-19-000011.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBkQAg&amp;usg=AOvVaw2zAerTPoVZCrxZXlcmoWwU">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 0001583648-19-000011.pdf - Pieris Pharmaceuticals, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.pieris.com › investors › sec-filings › all-sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 18, 2019
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... on December 17, 2014. Pieris GmbH (formerly Pieris AG, a German company which was founded in 2001) continues as an operating subsidiary of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBYQAg" href="/url?q=https://doc.morningstar.com/1aafcc04b00a48c868fb3638b4bf5668.msdoc/%3Fclientid%3Dfiduk%26key%3D06f7d682c5869576&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBYQAg&amp;usg=AOvVaw3LzIYxO1EUPrzF4dlWcNB3">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           10-K - Morningstar Document Library
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          doc.morningstar.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... control over financial reporting under Section 404(b) of the Sarbanes-Oxley ... INCORPORATED. ANNUAL REPORT ON FORM 10-K. TABLE OF CONTENTS. PART I. Item 1 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBcQAg" href="/url?q=https://oxfordre.com/business/display/10.1093/acrefore/9780190224851.001.0001/acrefore-9780190224851-e-38%3Fp%3DemailAgyUL06.g4WS.%26d%3D/10.1093/acrefore/9780190224851.001.0001/acrefore-9780190224851-e-38&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBcQAg&amp;usg=AOvVaw0sQaZiV1c6doko2tAoebhd">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Open Innovation | Oxford Research Encyclopedia of Business and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          oxfordre.com › display › acrefore › acrefore-9780190224851-e-38 › acref...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 19, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Open Innovation, published in 2003, was a ground-breaking work by Henry Chesbrough that placed technology and innovation at the center of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBMQAg" href="/url?q=https://dukespace.lib.duke.edu/bitstreams/d1968ac4-835f-4490-b92c-e0ee2e0b8af8/download&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBMQAg&amp;usg=AOvVaw3xJ2_S-td2y_1OVUywOlex">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Essays on Corporate Investment in Scientific Research - DukeSpace
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          dukespace.lib.duke.edu › bitstreams › download
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           independently in 2005 after it was acquired by “SBC COMMUNICATIONS INC” ... as a subsidiary name under the Time-Warner UO company. PHARMACIA, UPJOHN and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBUQAg" href="/url?q=https://investor.verastem.com/static-files/00fdced5-88f6-4070-bc00-67471814db2f&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBUQAg&amp;usg=AOvVaw16iSD7yps9FUgKoRa4eGok">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Download DOC - Verastem, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.verastem.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Verastem, Inc. (Exact name of registrant as specified in ... TNBC returns more often than other types of breast cancer in part because there are CSCs that are not ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBQQAg" href="/url?q=https://valneva.com/wp-content/uploads/2019/06/Registration_Document_2017.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBQQAg&amp;usg=AOvVaw2Y2zXTtoavOdGYVwZAuxC7">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Registration Document - Valneva
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          valneva.com › wp-content › uploads › 2019/06 › Registration_Docu...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           division or subsidiary, on investments in any business division or on the acquisition of any ... management board of the Company or its subsidiary ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBIQAg" href="/url?q=https://investor.bluebirdbio.com/static-files/e394b8b4-481e-4e58-baf6-b1c368721165&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBIQAg&amp;usg=AOvVaw2i6LJtAPf7zLqQLc_b46xI">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] bluebird bio, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.bluebirdbio.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBEQAg" href="/url?q=https://www.hutch-med.com/wp-content/uploads/2017/03/2016-Form-20-F.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBEQAg&amp;usg=AOvVaw2Y-CltDQLtvn6sEuHFXeq2">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] FORM 20-F
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.hutch-med.com › uploads › 2017/03 › 2016-Form-20-F
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 10, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... company listed on the Shanghai Stock Exchange and the. Hong Kong Stock Exchange;. • “Hain Celestial” are to The Hain Celestial Group, Inc., a ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBAQAg" href="/url?q=https://www.cam.ac.uk/system/files/cu_annual_report_2014.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECBAQAg&amp;usg=AOvVaw1d5VSz4aushwpYTzwfMGhM">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Reports and Financial Statements for the year ended 31 July 2014
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cam.ac.uk › system › files › cu_annual_report_2014
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 24, 2014
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The University operates in a number of different classes of business. ... t HOTmaths Pty Limited is a 55% subsidiary incorporated in Australia.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAsQAg" href="/url?q=https://www.hcplive.com/view/articles_pfn_feb2008&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAsQAg&amp;usg=AOvVaw3u2PNML_fjJ4Lc7KIfyyfK">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Physicians' Financial News: February 2008 - HCPLive
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.hcplive.com › view › articles_pfn_feb2008
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 23, 2010
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Company insiders report that the MGI Pharma acquisition is merely the latest step in a larger strategic plan that Eisai has methodically ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAoQAg" href="/url?q=https://hbr.org/1998/11/clusters-and-the-new-economics-of-competition&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAoQAg&amp;usg=AOvVaw0E_WxQJ8eoLZJdslxfuLwO">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Clusters and the New Economics of Competition
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          hbr.org › 1998/11 › clusters-and-the-new-economics-of-competition
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... company, upgrading the cluster should be part of management's agenda. Companies upgrade their clusters in a variety of ways. Consider Genzyme. Massachusetts ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAkQAg" href="/url?q=https://scpharmaceuticalsinc.gcs-web.com/node/6651/html&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAkQAg&amp;usg=AOvVaw2ApANYQtgG6av7mdvQgYQn">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | scPharmaceuticals, Inc. - Investor Overview
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          scpharmaceuticalsinc.gcs-web.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Delivery of the shares of common stock is expected to be made on or about , 2017. We have granted the underwriters an option for a period of 30 days to purchase ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAwQAg" href="/url?q=https://www.neurocrine.com/wp-content/uploads/2021/12/2019_Annual_Report.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAwQAg&amp;usg=AOvVaw2XuVKfjI_-_s02-dgayzvO">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 2019 Annual Report | Neurocrine Biosciences
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.neurocrine.com › wp-content › uploads › 2021/12 › 2019_Ann...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... under an employee benefit plan of the Company or any Subsidiary, ... in the ownership or effective control of the Company, or in the ownership.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECA0QAg" href="/url?q=https://www.gensight-biologics.com/wp-content/uploads/2018/03/1464157520_gensight-biologics_document-de-base_20160524.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECA0QAg&amp;usg=AOvVaw1c1Gr9M3N9or6fkW-GD75P">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] GenSight Biologics S.A. Corporation (société anonyme) with a share ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.gensight-biologics.com › wp-content › uploads › 2018/03 › 14...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Wyzga served in various senior management positions at Genzyme. Corporation, a publicly traded global biotechnology company. Mr. Wyzga joined Genzyme in.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECA8QAg" href="/url?q=https://web.stanford.edu/~rkatila/new/pdf/Katilasharks.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECA8QAg&amp;usg=AOvVaw3Zm7b4iEQp5X1Xw6oqQZmo">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] SWIMMING WITH SHARKS: TECHNOLOGY VENTURES AND ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          web.stanford.edu › ~rkatila › new › pdf › Katilasharks
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corporate investment. Recent research looks at investment relationships in new firms when the investor is a corporation. This work takes the corporate ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECA4QAg" href="/url?q=https://www.bcbsla.com/-/media/Medical%2520Policies/2020/08/03/17/33/AutologousChondrocyteImplantationforFocalArticularCartilageLesions.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECA4QAg&amp;usg=AOvVaw0lQkwq6zBWOopaeX-BiDxM">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Autologous Chondrocyte Implantation for Focal Articular Cartilage ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bcbsla.com › media › 2020/08/03 › AutologousChondrocyteIm...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 3, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Used With Autologous Bone Marrow) is addressed separately in medical policy 00258. ... Trends in the Orthopaedic Literature, Part II: Lower ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAgQAg" href="/url?q=https://s2.q4cdn.com/767477267/files/doc_financials/annual/Waters-20Corporation-20(WAT)-202007-20Annual-20Report-20(FINAL).pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAgQAg&amp;usg=AOvVaw1HoAvhjBvPT88YjmeDLV8l">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] [ 2007 ANNUAL REPORT ]
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          s2.q4cdn.com › files › doc_financials › annual
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 2, 2008
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... in a subsidiary and for the deconsolidation of a subsidiary. This ... management in the event of a change in control of the Company, and to.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAUQAg" href="/url?q=https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2018/05/15175828/Universal-registration-document-2017-1.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAUQAg&amp;usg=AOvVaw3GOgBoOg7YJzYppEy5-DN-">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] PURSUING DIALOGUE for patient care - Ipsen
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ipsen.com › 2018/05 › Universal-registration-document-2017-1
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Legal Form and applicable laws. The Company is a limited liability company incorporated under French law with a Board of Directors governed by the provisions ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAAQAg" href="/url?q=https://www.asn-online.org/publications/kidneynews/archives/2019/KN_2019_10_oct.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAAQAg&amp;usg=AOvVaw2oUGXR2kkaznmgsBNUxxik">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Kidney News - American Society of Nephrology
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.asn-online.org › kidneynews › archives › KN_2019_10_oct
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Oct 1, 2019
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           KAI Pharmaceuticals, Inc., a wholly owned subsidiary of Amgen, Inc. ... with over $2 billion under management and offices in Boston, Silicon ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAEQAg" href="/url?q=https://meridian.allenpress.com/ijmsc/article-pdf/17/S1/1/2090224/1537-2073-17_s1_1.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAEQAg&amp;usg=AOvVaw3TzCOTW5IUv3xWoAKBrmlM">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           2015 2015 Annual Meeting of the CMSC - Allen Press
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          meridian.allenpress.com › ijmsc › article-pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 29, 2015
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           in the management of challenging MS patients. Supported by: EMD Serono, Inc, a subsidiary of Merck KGaA; Pfizer Inc; Gen- zyme, a Sanofi company.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAYQAg" href="/url?q=https://www.kaken.co.jp/english/invest/library/pdf/annual_report/cr_2018.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAYQAg&amp;usg=AOvVaw1cOz7kkQo78Y3FOo5DvAvj">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] CORPORATE REPORT 2018
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.kaken.co.jp › english › invest › library › pdf › annual_report
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 1, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           professional expertise gained through engaging in corporate legal work as an attorney at law in the management of the Company. Director.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAQQAg" href="/url?q=https://www.kidney.org/sites/default/files/docs/cm08_program.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAQQAg&amp;usg=AOvVaw30Zy9EZwAK3FTf3EP37Hmv">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Keep up with KEEPTM - National Kidney Foundation
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.kidney.org › sites › default › files › docs › cm08_program
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 5, 2008
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Boehringer ingelheim Pharmaceuticals, inc., the uS subsidiary of. Boehringer ingelheim, headquartered in germany, operates globally in. 47 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAIQAg" href="/url?q=https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/000000/000115/unrestricted/20030190e.pdf&amp;sa=U&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QFnoECAIQAg&amp;usg=AOvVaw3nBSxWhRgN2xbdkKtP-2Hy">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] venture capital funds annual report july 2002
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          msa.maryland.gov › megafile › msa › speccol › unrestricted
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jul 22, 2002
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           As an independent control mechanism for this investment initiative, an outside Advisory Board ... Genzyme Inc. in Cambridge,. Massachusetts, Cell ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad xpd EtOod pkphOe">
     <div class="K8tyEc">
      <div class="mEUgP">
       <span>
        <div class="BNeawe">
         People also search for
        </div>
       </span>
      </div>
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAI" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Sanofi&amp;sa=X&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAI">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           Sanofi
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAQ" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Edgar&amp;sa=X&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAQ">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           Edgar
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAY" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Sanofi+subsidiaries&amp;sa=X&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAY">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           Sanofi subsidiaries
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAg" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Sanofi+SEC+filings&amp;sa=X&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAg">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           Sanofi SEC filings
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAo" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=form+20-f&amp;sa=X&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAo">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           form 20-f
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAw" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Sanofi-Aventis&amp;sa=X&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEAw">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           Sanofi-Aventis
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEA4" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Sanofi+Annual+Report+2023&amp;sa=X&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEA4">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           Sanofi Annual Report 2023
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEBA" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=SANOFI+AVENTIS+PARTICIPATIONS&amp;sa=X&amp;ved=2ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q1QJ6BAgHEBA">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           SANOFI AVENTIS PARTICIPATIONS
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
    </div>
   </div>
   <footer>
    <div>
     <div class="Gx5Zad xpd EtOod pkphOe BmP5tf">
      <div class="nMymef Va3FIb lVm3ye">
       <a aria-label="Next page" class="nBDE1b G5eFlf" href="/search?q=Is+Focal,+Inc.+a+subsidiary+that+operates+independently+or+under+Genzyme%27s+control%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=cKaWZu-1C7iMvr0P-KvU-A0&amp;start=100&amp;sa=N">
        Next &gt;
       </a>
      </div>
     </div>
    </div>
    <div id="EOlPnc">
     <div class="Srfpq">
      <div>
       <span class="EYqSq unknown_loc">
       </span>
       <span class="dfB0uf">
        Unknown
       </span>
      </div>
      <span>
       Can't determine location
      </span>
      <span>
       -
      </span>
      <a aria-label="Learn more about this location" class="IffyKc" href="/url?q=https://support.google.com/websearch%3Fp%3Dws_settings_location%26hl%3Den&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Qty4I7QM&amp;usg=AOvVaw2e9iT6y8nu8x4GHR2DWW7s" tabindex="0">
       Learn more
      </a>
     </div>
     <div>
      <a href="/url?q=https://accounts.google.com/ServiceLogin%3Fcontinue%3Dhttps://www.google.com/search%253Fhl%253Den%2526source%253Dhp%2526q%253DIs%252BFocal,%252BInc.%252Ba%252Bsubsidiary%252Bthat%252Boperates%252Bindependently%252Bor%252Bunder%252BGenzyme%252527s%252Bcontrol%25253F%2526btnG%253DGoogle%252BSearch%2526iflsig%253DAL9hbdgAAAAAZpa0fzCUda8Isoo66B6MXiluKkZXzuXc%2526gbv%253D1%2526lr%253Dlang_en%2526gl%253Dus%2526num%253D100%26hl%3Den&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Qxs8CCO4D&amp;usg=AOvVaw3N2Ho8JhuR8BPJL5IPK4im">
       Sign in
      </a>
     </div>
     <div>
      <a class="xeDNfc" href="https://www.google.com/preferences?hl=en&amp;fg=1&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8Q5fUCCO8D">
       Settings
      </a>
      <a class="xeDNfc" href="https://policies.google.com/privacy?hl=en&amp;fg=1">
       Privacy
      </a>
      <a class="xeDNfc" href="https://policies.google.com/terms?hl=en&amp;fg=1">
       Terms
      </a>
      <a class="xeDNfc" href="/setprefs?hl=en&amp;prev=https://www.google.com/search?hl%3Den%26source%3Dhp%26q%3DIs%2BFocal,%2BInc.%2Ba%2Bsubsidiary%2Bthat%2Boperates%2Bindependently%2Bor%2Bunder%2BGenzyme's%2Bcontrol?%26btnG%3DGoogle%2BSearch%26iflsig%3DAL9hbdgAAAAAZpa0fzCUda8Isoo66B6MXiluKkZXzuXc%26gbv%3D1%26lr%3Dlang_en%26gl%3Dus%26num%3D100%26pccc%3D1&amp;sig=0_Ft4ci29-rUQsarGisS2PW01-D1Q%3D&amp;cs=2&amp;sa=X&amp;ved=0ahUKEwjvrZXpg6yHAxU4hq8BHfgVFd8QjcAJCPAD">
       Dark theme: Off
      </a>
     </div>
    </div>
   </footer>
  </div>
  <!-- cctlcm 5 cctlcm -->
  <textarea class="csi" name="csi" style="display:none"></textarea>
 </body>
</html>
